Drug development costs are increasing and the time it takes to bring a drug to market is becoming longer. Also of consideration is the success rate for receiving regulatory approval to market your drug or device.The increasing cost of clinical research has significant implications for...
Only 10% of all drugs in human clinical trials become an approved drug. Nevertheless, clinical trials are imperative for discovering novel treatments to ever-changing diseases, and patients are an integral part of it. Sadly though, 30% of clinical trials never even get off the ground...
While President Trump believes that ‘slow and burdensome’ FDA drug approval process is ‘keeping too many new drugs from reaching the market’, former FDA Director Rob Califf differs in his opinion when he says that ‘Drug regulation drives innovation’. Rob Califf, a cardiologist goes on to...
Apple launched ResearchKit in 2015, since then we have seen a number of medical research studies from nonprofits, academic medical centers and pharmaceuticals across the country. There has been a lot of interest among clinicians and healthcare professionals and the first year alone saw the launch...
Many new and exciting mega research initiatives caught our attention in 2016. These research initiatives taken during the Obama presidency with continued support by the Trump administration have the potential to change the face of healthcare and clinical research in the coming years. Let’s have...
We started the year 2016 with the launch of our first cross-platform researchkit study app called America Walks in February 2016 to determine walking behavior of Americans. This set the momentum for the rest of the year for us. We attended some great conferences and had...